政府料本財年需90億元採購新冠疫苗和推行接種
食物及衛生局估算,本財政年度將需要90億元採購新冠疫苗和推行接種計劃。局方回應立法會議員提問時表示,預算開支90億元的其中30億元,是來自上年度未動用的款項,60億元為本年度新承擔金額。
當中採購疫苗預料需45.8億元,推展接種計劃需38.9億元,預算中的其他開支,包括運送和儲存疫苗、宣傳和建立網上平台等,4.6億元將預留作應急費用。
食衛局表示,會持續密切留意疫苗發展,並保持與疫苗生產商聯繫,不時尋求專家意見,以決定採購疫苗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.